RxDoctor Payments Data

Joan Halley, DO

Family Medicine · Gig Harbor, WANPI 1013994565

Payments from drug & device makers

$876in general payments, 2019–2025

Across 42 payments — averaging $20.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$177
  • Novo Nordisk$105
  • Boehringer Ingelheim$67
  • Lilly USA, LLC$63
  • AstraZeneca$60
  • Sanofi Pasteur Inc.$40
  • plus $363 from 16 others

What the payments were for

  • Food & beverage$876100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$876 in reported general payments places this provider in the 80th percentile of 2,275 family medicine providers in Washington.

See all family medicine providers in Washington

Medicare billing

Part B allowed, 2024
$98,175
Medicare patients
289
Services billed
2,013

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban25$39,355
JardianceEmpagliflozin36$38,738
EliquisApixaban22$19,666
MounjaroTirzepatide12$14,948
MyrbetriqMirabegron25$13,263
OzempicSemaglutide12$10,796
OxycontinOxycodone Hcl12$9,147
BrilintaTicagrelor19$5,802
SymbicortBudesonide/Formoterol Fumarate19$4,778
Advair HfaFluticasone Propion/Salmeterol11$3,648
Atorvastatin Calcium264$2,782
Levothyroxine Sodium213$2,311
Lantus SolostarInsulin Glargine,hum.Rec.Anlog19$2,296
Gabapentin95$2,241
Bupropion XlBupropion Hcl111$2,190

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$16$39,35525 claims
Boehringer IngelheimJardiance$67$38,73836 claims
PfizerEliquis$38$19,66622 claims
Lilly USA, LLCMounjaro$63$14,94812 claims
Novo NordiskOzempic$105$10,79612 claims
AstraZenecaBrilinta, Symbicort$60$10,58038 claims
AbbVieSynthroid$177$77225 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,275 family medicine providers in Washington.

Other family medicine in Gig Harbor

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →